19.12.2023 - Additional clinical research indicates patients using ProSomnus devices have decreased apnea-hypopnea index events per hour, with strong treatment adherencePLEASANTON, Calif., Dec. 19, 2023 (GLOBE NEWSWIRE) - ProSomnus, Inc. (NASDAQ: OSA) (the . Seite 1
The anti-snoring devices market is expanding due to a variety of factors such as rising obesity rates and an increase in the elderly population. Furthermore, rising smoking and alcohol consumption